MS Studies on the Metabolomics Workbench Containing Lipids

These studies were depositied in the NIH Metabolomics Data Repository from institutions around the world, and are hosted on the Metabolomics Workbench. Search, sort, and filter using the options below. Links lead to the Metabolomics Workbench website.

EI: Electron ionization(GC-MS); ESI: Electrospray ionization (LC-MS)

Search:

  Records per page  

Fields searched:
Study Title, Institute, Subject Species, MS Type (case insensitive)

Study Title
Institute
Subject Species
MS Type
Number of lipids
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Small Intestine - Untargeted HILIC-Positive (ST002674) Broad Institute of MIT and Harvard Rattus norvegicus ESI 96
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Reversed-Phase Positive (ST002673) University of Michigan Rattus norvegicus ESI 95
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Reversed-Phase Negative (ST002672) University of Michigan Rattus norvegicus ESI 67
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Lipidomics, Reversed-Phase Positive (ST002671) Georgia Institute of Technology Rattus norvegicus ESI 418
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Lipidomics, Reversed-Phase Negative (ST002670) Georgia Institute of Technology Rattus norvegicus ESI 181
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted HILIC-Positive (ST002668) Broad Institute of MIT and Harvard Rattus norvegicus ESI 98
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Ovaries - Untargeted HILIC-Positive (ST002667) Broad Institute of MIT and Harvard Rattus norvegicus ESI 97
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Testes - Untargeted HILIC-Positive (ST002666) Broad Institute of MIT and Harvard Rattus norvegicus ESI 91
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Spleen - Untargeted HILIC-Positive (ST002665) Broad Institute of MIT and Harvard Rattus norvegicus ESI 93
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Colon - Untargeted HILIC-Positive (ST002664) Broad Institute of MIT and Harvard Rattus norvegicus ESI 96
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:White Adipose - Targeted Acyl-CoA (ST002663) Duke University Rattus norvegicus ESI 64
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Liver - Targeted Acyl-CoA (ST002662) Duke University Rattus norvegicus ESI 64
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Heart - Targeted Acyl-CoA (ST002661) Duke University Rattus norvegicus ESI 64
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Gastrocnemius - Targeted Acyl-CoA (ST002660) Duke University Rattus norvegicus ESI 64
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Adrenal - Untargeted HILIC-Positive (ST002659) Broad Institute of MIT and Harvard Rattus norvegicus ESI 100
NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? (ST000253) University of California, Davis Rattus norvegicus ESI 75
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 (ST003036) Monash Institute of Pharmaceutical Sciences Pseudomonas aeruginosa ESI 136
Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals (ST002447) Sharjah Institute for Medical Research Pseudomonas aeruginosa ESI 57
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 (ST003024) Monash Institute of Pharmaceutical Sciences Pseudomonas aeruginosa ESI 34
Metabolomic profiles in P. gingivalis treated with curcumin (ST002879) Osaka University Porphyromonas gingivalis ATCC33277 ESI 21
Metabolomic profiles in P. gingivalis cells treated with pABA (ST000384) Osaka University Porphyromonas gingivalis ATCC 33277 ESI 34
Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites (ST001205) Monash University Plasmodium falciparum;Homo sapiens ESI 234
Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites (ST001204) Monash University Plasmodium falciparum;Homo sapiens ESI 200
Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites (ST001202) Monash University Plasmodium falciparum;Homo sapiens ESI 194
Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites (ST001201) Monash University Plasmodium falciparum;Homo sapiens ESI 167
Retargeting azithromycin-like compounds as antimalarials with dual modality (ST001315) Monash University Plasmodium falciparum ESI 114
Elucidating the source of elevated proline in APR parasites (ST004222) Broad Institute of MIT and Harvard Plasmodium falciparum ESI 27
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 (ST003179) Monash University Plasmodium falciparum ESI 286
Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression (ST002926) Monash University Plasmodium falciparum ESI 128
Determination of mode of action of anti-malalrial drugs using untargeted metabolomics (ST001033) Monash University Plasmodium falciparum ESI 135
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) (ST002106) Monash University Plasmodium falciparum ESI 113
New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites (ST003160) Monash University Plasmodium falciparum ESI 166
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity (ST003144) Monash University Plasmodium falciparum ESI 190
Validating the role of the arginine to proline biosynthetic pathway in the APR (ST004233) Broad Institute of MIT and Harvard Plasmodium falciparum ESI 27
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) (ST002108) Monash University Plasmodium falciparum ESI 212
Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum (ST001175) Monash University Plasmodium falciparum ESI 168
Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action (ST000414) Monash Institute of Pharmaceutical Sciences Plasmodium falciparum ESI 148
Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria (ST002792) Monash University Plasmodium falciparum ESI 189
Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells (ST003565) Monash University Plasmodium falciparum ESI 287
Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium (ST000546) Monash University Plasmodium falciparum ESI 146
Targeting malaria parasites with novel derivatives of azithromycin (ST002309) Monash University Plasmodium falciparum ESI 113
PfApiAT2 loss of function leads to Adaptive Proline Response (APR) (ST004240) Broad Institute of MIT and Harvard Plasmodium falciparum ESI 27
Labeled amino acid uptake from multiplexed isotope media (ST004239) Broad Institute of MIT and Harvard Plasmodium falciparum ESI 27
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) (ST002107) Monash University Plasmodium falciparum ESI 152
Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites (ST002698) Peter Doherty Institute for Infection and Immunity Plasmodium berghei ESI 98
Needle leachates of Pinus koraiensis from May to September (ST003309) Yunnan University Pinus koraiensis EI 78
Metabolic Profiling of Date Palm Fruits (ST000508) Weill Cornell Medicine, Qatar Phoenix dactylifera ESI 71
Metabolic Profiling of Date Palm Fruits (part II) (ST000867) Weill Cornell Medicine, Qatar Phoenix dactylifera ESI 71
Maternal obesity alters offspring liver and skeletal muscle metabolism in early post-puberty despite maintaining a normal post-weaning dietary lifestyle (ST002254) Wake Forest School of Medicine Papio hamadryas EI 60
High Resolution GC-MS Metabolomics of Non-Human Primate Serum (ST000972) Wake Forest School of Medicine Papio hamadryas EI 55

Number of records: 1427

previous 50 records     next 50 records